Clinical Trial Update: A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating MK-0683 for efficacy in Polycythemia Vera and Essential Thrombocythemia; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia
• Polycythemia Vera

Drugs mentioned

• MK-0683

Snippet

Sponsor: Copenhagen University Hospital at Herlev | Conditions: Polycythemia Vera, Essential Thrombocythemia | Phase 2 | Status: UNKNOWN